Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007169
Abstract: Key Points • OxLDL enhances GPVI-driven platelet procoagulant activity ex vivo.• P2YR antagonists and tyrosine kinase inhibitors may reduce oxLDL-enhanced platelet procoagulant activity more so than aspirin.
read more here.
Keywords:
kinase inhibitors;
effect antiplatelet;
activity;
tyrosine kinase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.871267
Abstract: Background The role of coronary artery calcium score (CACS) to guide antiplatelet therapy in order to prevent myocardial infarction (MI) is still uncertain. This study aimed to find the causal relationship of CACS on MI…
read more here.
Keywords:
effect antiplatelet;
antiplatelet therapy;
therapy;
preventive effect ... See more keywords